RM
Rambabu Medisetty
About Rambabu Medisetty
Rambabu Medisetty has 12 years in corporate governance. Holds Additional Director and Director roles. Currently with 6 companies, including Neorx Drugs India Private Limited and Mediviz Healthcare Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Neorx Drugs India Private Limited
U24230TG2018PTC125158
|
Additional Director | 06 May 2019 | 2018 | Active |
Mediviz Healthcare Private Limited
U24299AP2021PTC118871
|
Director | 19 Jul 2021 | 2021 | Active |
Ckolon It Consulting Private Limited
U72900KA2018PTC115470
|
Director | 21 Mar 2019 | 2018 | Active |
Mediviz Pharma Services Private Limited
U74900AP2013PTC091376
|
Managing Director | 28 Nov 2013 | 2013 | Active |
Medla Sciences Llp
AAZ-8409
|
Designated Partner | 10 Dec 2021 | 2021 | Active |
Cedar Life Care Private Limited
U21001AP2025PTC118065
|
Director | 28 Feb 2025 | 2025 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rambabu Medisetty
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rambabu Medisetty
Rambabu Medisetty has 12 years in corporate governance. Holds Additional Director and Director roles. Currently with 6 companies, including Neorx Drugs India Private Limited and Mediviz Healthcare Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Rambabu Medisetty is associated with 6 companies as Additional Director and Director.
Rambabu Medisetty has expertise in General Business, Healthcare.
Rambabu Medisetty has 12 years in corporate governance.